arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Cosmos Health Inc.

COSM
$0.23 ▲ +0.01 (+6.58%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

Cosmos Health Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $7.0M
Dividend Yield
Revenue Growth 19.9%
Op. Margin -25.6%
ROIC -75.2%
FCF / Share $-0.28
Trailing P/E
Price / Book 0.5x
FCF Yield
Debt / Equity 0.20
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$65.27M
↑ +19.9%
Net Income Profit after all expenses
$-19.14M
↓ -18.3%
Operating Margin Operating profit as % of sales
-25.6%
↑ +10.4% 9th
FCF / Share Free cash flow per share
$-0.28
↑ +33.9%
Long-Term Debt Long-term obligations
$3.78M
↓ -8.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
8
Financial Health
52
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 69 quarters